JulieASettlesNP

Acute Care Nurse Practitioner • Indianapolis, IN

Senior Director Scientific Affairs Eli Lilly and Company

Join to view full profile

Julie A Settles is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Julie Settles' full profile

Already have an account?

Education & Training

Indiana University – Purdue University IndianapolisMasters, 2002

Publications & Presentations

PubMed

44 citations
TWO TREATMENT APPROACHES FOR HUMAN REGULAR U-500 INSULIN IN PATIENTS WITH TYPE 2 DIABETES NOT ACHIEVING ADEQUATE GLYCEMIC CONTROL ON HIGH-DOSE U-100 INSULIN THERAPY WI...
Robert C. Hood, Richard Arakaki, Carol Wysham, Ying G. Li, Julie Settles
Endocrine Practice. 2015-03-26
16 citations
Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analys...
Samaneh Kabul, Robert C. Hood, Ran Duan, Amy M. DeLozier, Julie Settles
Health and Quality of Life Outcomes. 2016-09-30
33 citations
GLUCAGON PRESCRIPTION PATTERNS IN PATIENTS WITH EITHER TYPE 1 OR 2 DIABETES WITH NEWLY PRESCRIBED INSULIN.
Beth Mitchell, Xuanyao He, Ian M. Sturdy, Andrew P. Cagle, Julie Settles
Endocrine Practice. 2016-02-01

Journal Articles

Previously unrecognized risk factors for severe hypoglycaemia requiring emergency medical care in insulin-treated type 2 diabetes: Results from a real-world nested cas...
Julie Settles MSN, Hong Kan PhD, Christopher J. Child PhD, Magdaliz Gorritz MPH, Jasjit K. Multani MPH, Catherine B. McGuiness MS, Rolin L. Wade MS, Brian M. Frier MD, Diabetes, Metabolism and Obesity, 3/9/2022

Office
1402 E County Line Rd
Indianapolis, IN 46227
Phone+1 317-887-7000